A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 8, 2004, Pages 1329-1330

  Grundy, Scott M ^a   Cleeman, James I ^b   Merz, C Noel Bairey ^b   Brewer Jr , H Bryan ^b   Clark, Luther T ^b   Hunninghake, Donald B ^b   Pasternak, Richard C ^b   Smith Jr , Sidney C ^b   Stone, Neil J ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; TRIACYLGLYCEROL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIABETES MELLITUS; EDITORIAL; EDUCATION PROGRAM; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LIFESTYLE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RISK FACTOR;

ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, LDL; CLINICAL TRIALS; CORONARY DISEASE; GOALS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; RISK; TRIGLYCERIDES;

EID: 3943087024     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000139012.45265.e0     Document Type: Editorial

References (0)